ARA In The News

February 2018
Doctors advised to stop performing arthroscopic knee surgery for osteoarthritis
Sydney Morning Herald interview with Rachelle Buchbinder on 6 February
3AW Interview with Rachelle Buchbinder on 6 February

October 2017
Five ‘do-not-do’ recommendations for rheumatology
The Limbic article with Rachelle Buchbinder

Concern over “unprecedented” intervention into biologics market
The Limbic article with Mona Marabani


Policy block to reverse substitution
Pharma Dispatch article with Mona Marabani


July 2017
Everything you wanted to know about oseoarthritis (and some things you thought you knew, but didn't)
Interview with Prof David Hunter on The Health Report with Dr Norman Swan 10 July 2017
For more information on the compound and clinical trial sites available in Australia, click here.

June 2017
6 of the best bits from the ARA Conference
Medical Observer article 1 June 2017

May 2017

"Five minutes with Professor Catherine Hill"
Professor Catherine Hill, ARA Honorary Secretary, interview for Rheumatology Update 25 May 2017


March 2017

"I want to raise the profile of rheumatology"

Professor Rachelle Buchbinder, ARA President, interview for Rheumatology Update 3 March 2017


December 2016

ARA says no to medical cannabis
Rheumatology Update 2 December 2016

October 2016

ARA opt for most 'rational' option on stem cell regulation
Nicola Garrett, thelimbic October 2016

A new frontier for vertebroplasty
Amanda Sheppeard, thelimbic October 2016

September 2016

MBS fails to address excessive imaging in Primary Care
Mardi Chapmen, thelimbic September 2016

August 2016

Young people get Arthritis too
9 News, metro North, 8 August 2016

Rheumatologists must navigate patients through complex world of biosimilars
Nicola Garrett, thelimbic 23 August 2016

July 2016

Caution required for Biosimilars
Sheshtyn Paula, ajp 6th October 2016

May 2016

Young people in NT struggling with arthritis
Katherine Gregory, ABC News 2nd May 2016

February 2016

Rheumatologists 'on back foot' with Inflectra data
Michelle Lam, pharma in focus, 8th February 2016

Biosimilars data plan remains unclear
Nick Lush, Pharma in focus 4th February 2016

December 2015

Prescribe infliximab by brand name, says ARA
thelimbic 1st December 2016